Insulet Corporation

-4.28 (-1.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)18.93B
Current PE2,127.31
Forward PE 379.07
2yr Forward PE 180.97
See more stats
Estimates Current Quarter
Revenue$258.97 Million
Adjusted EPS$0.13
See more estimates
10-Day MA$278.29
50-Day MA$270.20
200-Day MA$257.56
See more pivots

Insulet Corporation Stock, NASDAQ:PODD

100 Nagog Park, 100 Nagog Park, Acton, Massachusetts 01720
United States of America
Phone: +1.978.600.7000
Number of Employees: 1900


Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.